Treating iron deficiency in patients with HFrEF: A review of the recent data for IV iron replacement therapy

Media formats available:

No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC.24
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
- Javed Butler, MD
Management of hyperkalemia in CKD and HFrEF
Management of hyperkalemia in CKD and HFrEF
Kidney Disease
Management of hyperkalemia in CKD and HFrEF
- George L. Bakris, MD
- David Bushinsky, MD
- Lars Lund, MD
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
ESC Congress 2023
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
- Amy Groenewegen, MD
Management of patients with CKD and HF complicated by hyperkalemia
Management of patients with CKD and HF complicated by hyperkalemia
Kidney Disease
Management of patients with CKD and HF complicated by hyperkalemia
- Ellie Kelepouris, MD
- Stephen J. Greene, MD

PACE-CME